Clinical Trial Update: A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia [Phase 3]

View source ↗

Summary

This document describes a Phase 3 treatment study protocol for acute lymphoblastic leukemia in participants aged 0-45 years, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Mats Heyman | Conditions: Leukemia, Acute Lymphoblastic | Phase 3 | Status: RECRUITING